167 related articles for article (PubMed ID: 7862891)
1. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors.
Emmanouil DE; Johnson CH; Quock RM
Psychopharmacology (Berl); 1994 Jun; 115(1-2):167-72. PubMed ID: 7862891
[TBL] [Abstract][Full Text] [Related]
2. Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test.
Li S; Quock RM
Pharmacol Biochem Behav; 2001 Apr; 68(4):789-96. PubMed ID: 11526978
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice.
Quock RM; Emmanouil DE; Vaughn LK; Pruhs RJ
Psychopharmacology (Berl); 1992; 107(2-3):310-4. PubMed ID: 1319602
[TBL] [Abstract][Full Text] [Related]
4. Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker.
Czech DA; Quock RM
Psychopharmacology (Berl); 1993; 113(2):211-6. PubMed ID: 7855183
[TBL] [Abstract][Full Text] [Related]
5. Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze.
Caton PW; Tousman SA; Quock RM
Pharmacol Biochem Behav; 1994 Jul; 48(3):689-92. PubMed ID: 7524106
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine receptor-mediated behavioral effects of nitrous oxide in the rat social interaction test.
Quock RM; Wetzel PJ; Maillefer RH; Hodges BL; Curtis BA; Czech DA
Pharmacol Biochem Behav; 1993 Sep; 46(1):161-5. PubMed ID: 8255907
[TBL] [Abstract][Full Text] [Related]
7. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
Ferris P; Seward E; Dawson GR
J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic effects of nitrous oxide in mice in the light-dark and holeboard exploratory tests.
Czech DA; Green DA
Psychopharmacology (Berl); 1992; 109(3):315-20. PubMed ID: 1365632
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice.
O'Neill AB; Brioni JD
Pharmacol Biochem Behav; 1994 Nov; 49(3):755-7. PubMed ID: 7862733
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
11. Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice.
Belzung C; Le Guisquet AM; Griebel G
Behav Pharmacol; 2000 Apr; 11(2):125-31. PubMed ID: 10877117
[TBL] [Abstract][Full Text] [Related]
12. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine receptor function in the chick social separation-stress procedure.
Watson GS; Roach JT; Sufka KJ
Exp Clin Psychopharmacol; 1999 May; 7(2):83-9. PubMed ID: 10340149
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
Dalvi A; Rodgers RJ
Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on synthetic flavonoids: comparison with diazepam.
Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ
Neuropharmacology; 1999 Jul; 38(7):965-77. PubMed ID: 10428415
[TBL] [Abstract][Full Text] [Related]
16. Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors.
Ishihara S; Hiramatsu M; Kameyama T; Nabeshima T
J Neural Transm Gen Sect; 1993; 91(1):27-37. PubMed ID: 8383983
[TBL] [Abstract][Full Text] [Related]
17. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
Chopin P; Briley M
Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
[TBL] [Abstract][Full Text] [Related]
18. Nitrous oxide induces feeding in the nondeprived rat that is antagonized by naltrexone.
Czech DA
Physiol Behav; 1995 Aug; 58(2):251-5. PubMed ID: 7568427
[TBL] [Abstract][Full Text] [Related]
19. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea.
Wolfman C; Viola H; Paladini A; Dajas F; Medina JH
Pharmacol Biochem Behav; 1994 Jan; 47(1):1-4. PubMed ID: 7906886
[TBL] [Abstract][Full Text] [Related]
20. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze.
Holmes A; Rodgers RJ
Neurosci Biobehav Rev; 1999 Nov; 23(7):971-80. PubMed ID: 10580311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
